Detection of Pulmonary Embolism With CECT

Completed · Phase 4

Conditions studied: Pulmonary Embolism

In brief

To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA

Key facts

Study ID

NCT00351754

Run by

Bracco Diagnostics, Inc

People needed

120

Starts

2006-07-01

Expected to finish

2006-11-01

Last updated by the study team

2008-01-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 yrs or older
• With suspected PE
• Referred for MDCTA of pulmonary arteries
• Signed informed consent

You may not qualify if…

• Pregnant and lactating females
• History of hypersensitivity to iodinated contrast agents
• Hyperthyroidism or pheochromocytoma
• Severe CHF
• Renal impairment
• Weight greater than 300 lbs
• Pacemaker
• Swan Ganz catheter
• Defibrillator or other intrathoracic metallic vascular device
• Received an investigational compound within 30 days of being in the study

Where it is running

• Bracco Diagnostics, Inc. — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.